Latest research
Latest corporate research
Latest tax enhanced reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Twitter icon
Created with Sketch.
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax enhanced research
Product reports for investors and advisors
Latest published research
Chesnara Plc
Good 2023 results set platform for future progress
11th Apr 2024
Tissue Regenix
Six consecutive periods of >20% growth
10th Apr 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax enhanced research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
94: How governance enables startup growth and how to start it well | Dermot Campbell of SEEIO
Stay up-to-date with the latest research
Sign up to our newsletter
Life Sciences research
Advanced Oncotherapy
Life Sciences
Delivery of LIGHT
By
Dr Martin Hall
15 Mar 2017
Tissue Regenix
Life Sciences
Addressing woundcare in the US
By
Dr Dorothea Hill
13 Mar 2017
Stay up-to-date with the latest research
Sign up to our newsletter
Collagen Solutions Plc
Life Sciences
Engineering cartilage repairs
By
Dr Martin Hall
13 Mar 2017
Collagen Solutions Plc
Life Sciences
Capital increase to support accelerated growth
By
Dr Martin Hall
14 Feb 2017
Allergy Therapeutics plc
Life Sciences
Disruptive peanut allergy vaccine
By
Dr Martin Hall
13 Feb 2017
Alliance Pharma Plc
Life Sciences
Potential of Diclectin
By
Dr Martin Hall
25 Jan 2017
Allergy Therapeutics plc
Life Sciences
Investment driving market share gains
By
Dr Martin Hall
20 Jan 2017
Diurnal Group Plc
Life Sciences
Infacort® – On track to market
By
Dr Martin Hall
19 Jan 2017
Prev
1
...
19
20
21